Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001310 · ClinicalTrials.gov registry record
Tissue Studies of Human Eye Diseases
A clinical trial, sponsored by National Eye Institute (NEI).
- Terminated
- Registry status
- 3,833
- Enrollment target
NCT00001310 is a clinical trial that was terminated before completion, run by National Eye Institute (NEI). The registered enrollment target is 3,833 participants.
The verdict
NCT00001310 was terminated before completion, sponsored by National Eye Institute (NEI).
- TERMINATED
- Registry status
- 3,833 participants
- Enrollment target
Study Summary
The purpose of this project is to diagnose and evaluate ocular and related tissues with various diseases such as conjunctival, corneal, uveal, vitreoretinal and optic nerve disorders, ocular degenerative, metabolic or genetic diseases and tumors. These will be studied using light microscopy, electron microscopy, confocal microscopy, immunohistochemistry, molecular pathological including polymerase chain reaction and in situ hybridization, as well as measuring the functions of cellular organelles, e.g., mitochondrial function. Lymphocytes in the peripheral blood as well as other involved biopsied tissues and ocular tissue will be compared and categorized by disease. Cytokines, chemokines or growth factors and/or other released molecules in the blood and ocular fluids will be also analyzed. Elucidating the relationship between the infiltrating cells, ocular resident cells, and their products in various diseases will help us to make diagnoses and increase our understanding of human ocular disorders. Patients who require eye surgery to treat an eye disease or other disease in which the eye is involved may participate in this study. Samples of eye tissue and fluid that are normally removed and discarded during eye surgery will instead be given to researchers for study. The tissues will be examined under microscope and studied using sophisticated chemical and biological tests. Immune cells from blood samples may also be examined. These studies will help better understand and diagnose the various eye diseases and to develop more attractive therapies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,833 participants |
| Start Date | 1992-03-05 |
| Est. Completion | 2015-09-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001310
The ClinicalTrials.gov registry entry for NCT00001310 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3,833 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001310 about?
NCT00001310 is a clinical study titled "Tissue Studies of Human Eye Diseases". The purpose of this project is to diagnose and evaluate ocular and related tissues with various diseases such as conjunctival, corneal, uveal, vitreoretinal and optic nerve disorders, ocular degenerative, metabolic or genetic diseases and tumors. These will be studied using light microscopy, electro...
What is the current status of trial NCT00001310?
This trial is currently terminated. The enrollment target is 3,833 participants. The study started on 1992-03-05. Estimated completion is 2015-09-16.
Who is sponsoring clinical trial NCT00001310?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.